Comment on analyses and conclusions of "microglial activity in people at ultra high risk of psychosis and in schizophrenia: An [11C]PBR28 PET brain imaging study"

American Journal of Psychiatry

Volumn 173, Issue 5, 2016, Pages 536-537

  Narendran, Raj ^a,b   Frankle, W Gordon ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; PBR28 C 11; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BRAIN SIZE; CEREBELLUM; ENZYME ACTIVITY; GENOTYPE; GRAY MATTER; HUMAN; LETTER; MICROGLIA; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOSIS; RADIATION DOSE DISTRIBUTION; RISK FACTOR; SCHIZOPHRENIA; WHITE MATTER; NEUROIMAGING;

HUMANS; NEUROIMAGING; POSITRON-EMISSION TOMOGRAPHY; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 84965166651     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2016.15111417     Document Type: Letter

References (5)

1. Khandaker GM, Cousins L, Deakin J, et al: Inflammation and immunity in schizophrenia: Implications for pathophysiology and treatment. Lancet Psychiatry 2015; 2:258-270
2. Bloomfield PS, Selvaraj S, Veronese M, et al: Microglial activity in people at ultra high risk of psychosis and in schizophrenia: An [11C]PBR28 PET brain imaging study. AmJ Psychiatry 2016; 173:44-52
3. Innis RB, Cunningham VJ, Delforge J, et al: Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 2007; 27:1533-1539
4. Lyoo CH, Ikawa M, Liow JS, et al: Cerebellum can serve as a pseudoreference region in Alzheimer disease to detect neuroinflammation measured with PET radioligand binding to translocator protein. J Nucl Med 2015; 56:701-706
5. Kenk M, Selvanathan T, Rao N, et al: Imaging neuroinflammation in gray and white matter in schizophrenia: An in-vivo PET study with [18F]-FEPPA. Schizophr Bull 2015; 41:85-93